0000899140-24-001093.txt : 20241022 0000899140-24-001093.hdr.sgml : 20241022 20241022153053 ACCESSION NUMBER: 0000899140-24-001093 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240828 FILED AS OF DATE: 20241022 DATE AS OF CHANGE: 20241022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cowen Aaron CENTRAL INDEX KEY: 0001869640 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40560 FILM NUMBER: 241386222 MAIL ADDRESS: STREET 1: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROKIDNEY CORP. CENTRAL INDEX KEY: 0001850270 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981586514 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 FRONTIS PLAZA BLVD. STREET 2: SUITE 250 CITY: WINSTON-SALEM STATE: NC ZIP: 27103 BUSINESS PHONE: 336-999-7028 MAIL ADDRESS: STREET 1: 2000 FRONTIS PLAZA BLVD. STREET 2: SUITE 250 CITY: WINSTON-SALEM STATE: NC ZIP: 27103 FORMER COMPANY: FORMER CONFORMED NAME: Social Capital Suvretta Holdings Corp. III DATE OF NAME CHANGE: 20210310 3 1 form3.xml X0206 3 2024-08-28 0 0001850270 PROKIDNEY CORP. PROK 0001869640 Cowen Aaron C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 true Class A ordinary shares, par value $0.0001 per share 11428937 I I Class A ordinary shares, par value $0.0001 per share 912329 I I Class A ordinary shares, par value $0.0001 per share 144917 I I Class A ordinary shares, par value $0.0001 per share 712583 D Notes are included on Exhibit 99.1 hereto. Notes are included on Exhibit 99.1 hereto. Notes are included on Exhibit 99.1 hereto. Notes are included on Exhibit 99.1 hereto. Notes are included on Exhibit 99.1 hereto. Exhibit List: Exhibit 99.1 - Explanation of Responses /s/ Aaron Cowen 2024-10-22 EX-99.1 2 s80184003.htm EXPLANATION OF RESPONSES


Exhibit 99.1

Explanation of Responses:

(1) Reflects Class A ordinary shares, par value $0.0001 per share, of ProKidney Corp. (the “Class A ordinary shares”) directly held by Averill Master Fund, Ltd. (the “Averill Fund”).
(2) Reflects Class A ordinary shares directly held by Averill Madison Master Fund, Ltd.. (the “Averill Madison Fund”).
(3) Reflects 144,917 Class A ordinary shares held by The Aaron Cowen 2012 Family Trust, which is for the benefit of certain immediate family members of Mr. Cowen and for which Mr. Cowen’s spouse serves as the trustee.
(4) Reflects 712,583 Class A ordinary shares directly held by Mr. Cowen.
(5) Mr. Cowen may be deemed to control Suvretta Capital Management, LLC, the investment manager of each of the Averill Fund and the Averill Madison Fund, and therefore may be deemed to beneficially own the Class A ordinary shares held by the Averill Fund and the Averill Madison Fund. Mr. Cowen disclaims beneficial ownership of the Class A ordinary shares reported herein except to the extent of any indirect pecuniary interest therein.